Bluesky Facebook Reddit Email

Fewer laboratory animals thanks to secondary nanobodies

Researchers at the Max Planck Institute for Biophysical Chemistry have developed secondary nanobodies that outperform traditional antibodies in key cell-biological applications. These nanobodies can be produced in large scale by bacteria, reducing the need for animals in antibody production and improving resolution in light microscopy.